Bronchodilator responsiveness and serum total IgE levels in families of probands with severe, early-onset COPD

European Respiratory Journal

Volumn 14, Issue 5, 1999, Pages 1009-1014

  Celedon, U C ^a,d   Speizer, F E ^a,d   Drazen, J M ^b,d   Weiss, S T ^a,d   Campbell, E J ^e   Carey, V J ^a   Reilly, J J ^b,d   Ginns, L ^c,d   Silverman, E K ^a,b,d  

^a CHANNING LABORATORY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF UTAH   (United States)

Author keywords

Bronchodilator response; Chronic obstructive pulmonary disease; Familial aggregation; Genetic epidemiology; Genetics; Immunoglobulin E

Indexed keywords

BRONCHODILATING AGENT; IMMUNOGLOBULIN E; SALBUTAMOL;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FAMILY STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; SPIROMETRY;

EID: 0344718672     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.99.14510099     Document Type: Article

References (31)

1. Feinleib M, Rosenberg HM, Collins JG, Delozier JE, Pokras R, Chevarley FM. Trends in COPD morbidity and mortality in the United States. Am Rev Respir Dis 1989; 140: S9-S18.
2. Kochanek KD, Hudson BL. Advance report of final mortality statistics, 1992. Mon Vital Stat Rep 1995; 43: 1-73.
3. Silverman EK, Speizer FE. Risk factors for the development of chronic obstructive pulmonary disease. Med Clin North Am 1996; 80: 501-522.
4. US Department of Health and Human Services. The health consequences of smoking: chronic obstructive lung disease. A report of the Surgeon General. US Department of Health and Human Services, Office on Smoking and Health, Bethesda, MD. 1984. (DHHS Publication No. (PHS)84-50205).
5. Burrows B, Knudson RJ, Cline MG, Lebowitz MD. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis 1977; 115: 195-205.
6. Silverman EK, Chapman HA, Drazen JM, et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 1998; 157: 1770-1778.
7. Lewitter FI, Tager IB, McGue M, Tishler PV, Speizer FE. Genetic and environmental determinants of levels of pulmonary function. Am J Epidemiol 1984; 120: 518-529.
8. Redline S, Tishler PV, Rosner B, et al. Genotypic and phenotypic similarities in pulmonary function among family members of monozygotic and dizygotic twins. Am J Epidemiol 1989; 129: 827-836.
9. Hankins D, Drage C, Zamel N, Kronenberg R. Pulmonary function in identical twins raised apart. Am Rev Respir Dis 1982; 125: 119-121.
10. Webster PM, Lorimer EG, Man SFP, Woolf CR, Zamel N. Pulmonary function in identical twins: comparison of non-smokers and smokers. Am Rev Respir Dis 1979; 119: 223-228.
11. Larson RK, Barman ML, Kueppers F, Fuedenberg HH. Genetic and environmental determinants of chronic obstructive pulmonary disease. Ann Intern Med 1970; 72: 627-632.
12. Kueppers F, Miller RD, Gordon H, Hepper NG, Offord K. Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. Am J Med 1977; 63: 336-342.
13. Cohen BH, Ball Jr WC, Brashears S, et al. Risk factors in chronic obstructive pulmonary disease (COPD). Am J Epidemiol 1977; 105: 223-232.
14. Vollmer WM, Johnson LR, Buist AS. Relationship of response to a bronchodilator and decline in forced expiratory volume in one second in population studies. Am Rev Respir Dis 1985; 132: 1186-1193.
15. Kanner RE. The relationship between airways responsiveness and chronic airflow limitation. Chest 1984; 86: 54-57.
16. Campbell AH, Barter CE, O'Connell JM, Huggins R. Factors affecting the decline of ventilatory function in chronic bronchitis. Thorax 1985; 40: 741-748.
17. Taylor RG, Joyce H, Gross E, Holland F, Pride NB. Bronchial reactivity to inhaled histamine and annual rate of decline in FEV1 in male smokers and exsmokers. Thorax 1985; 40: 9-16.
18. Silverman EK, Province MA, Rao DC, Pierce JA, Campbell EJ. A family study of the variability of pulmonary function in alpha-1-antitrypsin deficiency. Quantitative phenotypes. Am Rev Respir Dis 1990; 142: 1015-1021.
19. Dockery DW, Ware JH, Ferris Jr BG, et al. Distribution of forced expiratory volume in one second and forced vital capacity in healthy, white, adult never-smokers in six US cities. Am Rev Respir Dis 1985; 131: 511-520.
20. Tager IB, Rosner B, Tishler PV, Speizer FE, Kass EH. Household aggregation of pulmonary function and chronic bronchitis. Am Rev Respir Dis 1976; 114: 485-492.
21. Ferris BG. Epidemiology standardization project. Am Rev Respir Dis 1978; 118 (Suppl): 1-120.
22. Gardner RM, Hankinson JL, Clausen JL, Crapo RO, Johnson Jr. RL, Epler GR. Standardization of spirometry: 1987 update. Official statement of the American Thoracic Society. Am Rev Respir Dis 1987; 136: 1285-1298.
23. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123: 659-664.
24. Kuperman AS, Riker JB. The variable effect of smoking on pulmonary function. Chest 1973; 63: 655-660.
25. Lieberman J, Winter B, Sastre A. Alpha-1-antitrypsin Pi-Types in 965 COPD patients. Chest 1986; 89: 370-373.
26. Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684-1689.
27. Postma DS, de Vries K, Koeter GH, Sluiter HJ. Independent influence of reversibility of airflow obstruction and nonspecific hyperreactivity on the long term course of lung function in chronic airflow obstruction. Am Rev Respir Dis 1986; 134: 276-280.
28. Anthonisen NR, Wright EC, and the IPPB Trial Group. Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133: 814-819.
29. O'Connor GT, Sparrow D, Weiss ST. The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140: 225-252.
30. Tashkin DP, Altose MA, Bleecker ER, et al. The Lung Health Study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. Am Rev Respir Dis 1992; 145: 301-310.
31. Dales R, Spitzer WO, Tousignant P, Schechter M, Suissa S. Clinical interpretation of airway response to a bronchodilator. Epidemiologic considerations. Am Rev Respir Dis 1988; 138: 317-320.